申请人:AMGEN INC.
公开号:US20150266824A1
公开(公告)日:2015-09-24
The present invention relates to a novel compound having a function of inhibiting RORγ activity. The present invention also relates to pharmaceutical composition comprising the compound, a use of the compound in treating or preventing autoimmune diseases, inflammatory diseases, metabolic diseases, or cancer diseases.
本发明涉及一种新型化合物,具有抑制RORγ活性的功能。本发明还涉及包含该化合物的药物组合物,以及使用该化合物治疗或预防自身免疫性疾病、炎症性疾病、代谢性疾病或癌症疾病的用途。